Oxford PharmaGenesis shares its social media expertise
As a leading healthcare communications company and a proud member of the Reciprocate network, Oxford PharmaGenesis takes its corporate social responsibilities very seriously.
March 16, 2026
We are pleased to announce the release of our ESG report for 2024/2025, which describes our collective progress across environmental sustainability, social responsibility and ethical governance.
As a leading healthcare communications company and a proud member of the Reciprocate network, Oxford PharmaGenesis takes its corporate social responsibilities very seriously.
Today, 28 February 2017, marks the 10th international Rare Disease Day and this year’s theme is ‘Research‘.
To mark World Cancer Day, we asked everyone at Oxford PharmaGenesis for their burning questions about cancer. We then asked our Oncology team to give their views on the most frequently asked questions – here is what they said.
Can the pharmaceutical industry help to advance the model for publishing of scientific research? This question has assumed greater importance as other funders have started to flex their muscles, introducing open access policies and even their own publishing platforms (e.g. Royal Society Open Science, Wellcome Open Research), but stringent regulation and widespread mistrust of open…
A group of budding knitters from the Oxford PharmaGenesis Oxford office answered the plea from Innocent to create knitted hats for their smoothie drinks by knitting more than 80 amazing hats!
With a company stand and a high level of participation in the programme, Oxford PharmaGenesis made a significant contribution to the European Meeting of the International Society for Medical Publication Professionals (ISMPP) held in London last week.